Inclusion and diversity in clinical trials: Actionable steps to drive lasting change.

ABSTRACT:

Background

Improving diversity in clinical trials is essential in order to produce generalizable results. Although the importance of representation has become increasingly recognized, identifying strategies to approach this work remains elusive. This article reviews the proceedings of a multi-stakeholder conference about the current state of diversity in clinical trials and outlines actionable steps for improvement.

Methods

Conference attendees included representatives from the United States Food and Drug Administration (FDA), National Institutes of Health (NIH), practicing clinical investigators, pharmaceutical and device companies, community-based organizations, data analytics companies, and patient advocacy groups. At this virtual event, attendees were asked to consider k

SUBMITTER: Kelsey MD 

PROVIDER: S-EPMC9133187 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature